The global mesalamine market size was US$ 169.5 million in 2021. The global mesalamine market size is forecast to reach US$ 212.6 million by 2030, registering a compound annual growth rate (CAGR) of 3 ...

Canasa (mesalamine) is a brand-name suppository that’s prescribed for ulcerative proctitis in adults. The cost of the drug, with and without insurance, can depend on several factors, such as ...

Canasa (mesalamine) is a brand-name rectal suppository prescribed for ulcerative proctitis. Canasa has interactions with some other drugs. Examples include nonsteroidal anti-inflammatory drugs ...

Chris Billam-Smith's world cruiserweight title unification fight with Gilberto Ramirez this Saturday is live on Sky Sports. Britain's Billam-Smith, the WBO champion, takes on WBA titlist Ramirez ...

A US court has upheld Shire's patent on its Lialda (mesalamine) ulcerative colitis delayed release tablets, in a legal tussle with Allergan subsidiaries Watson Pharma and Watson Laboratories.